Gut microbiome a predictor for type 2 diabetesThursday, 9 July 2020
Researchers have found that the composition and function of bacteria in the human intestine – the so-called gut microbiome – changes as the day progresses. These changes may help predict type 2 diabetes.
In a study comprising more than 400 participants undertaken by the Technical University of Munich (TUM) looking at the microbiome and diabetes, it was found these daily variations cease to exist in people living with type 2 diabetes.
Gut bacteria and medical conditions
The microbial composition of the intestines is complex and varies widely from one individual to another. Many factors such as environmental factors, lifestyle, genetics or illnesses affect the intestinal ecosystem of helpful gut bacteria.
Dirk Haller, Professor for Nutrition and Immunology at TUM, and his team have examined the importance of daytime-dependent fluctuations of the gut microbiome in relation to type 2 diabetes.
“In order to see whether changes in the gut microbiome allow conclusions about medical conditions, so-called prospective cohort studies are required,” explained Prof. Haller.
In these prospective cohort studies, a cross section of the population is being observed; however, none of the participants showed any signs of disease. This population is being re-examined over time. This way, researchers can find out whether a certain observation may be typical for future occurrences of diseases.
Diagnosis and outlook of type 2 diabetes may be improved
“When certain gut bacteria do not follow a day-night rhythm, that is, if their number and function does not change over the course of the day, this can be an indicator for a potential type 2 diabetes.
Knowing this can improve diagnosis and outlook of type 2 diabetes,” said Dr. Silke Kiessling, a contributor to the study.
These arrhythmic bacteria – those that are not changing between day and night – are a marker for potential disease. Researchers refer to this as a risk signature.
“Mathematical models also show that this microbial risk signature consisting of arrhythmic bacteria helps diagnosing diabetes,” said Dr Kiessling.
Primarily, the scientists analyzed data from an existing independent cohort from Munich. The diabetes-related results were validated using additional cohorts from Germany. “By comparing our data to cohorts in England, we could confirm that there is – among other things – a strong regional factor affecting the microbial ecosystem. Therefore, there is a demand for finding locally specified arrhythmic risk signatures,” elaborated Haller.
Dr Haller emphasizes that “apart from bacteria and their variations over the course of the day, other parameters such as the body mass index play a role in being able to better predict a person’s future medical conditions.”
A starting point for further research
Registering the time of day when taking human fecal samples for research purposes can heavily influence disease diagnostics. “Documenting these timestamps is essential for improving risk markers,” Prof. Haller emphasizes.
This research substantiates the hypothesis that changes in the microbiome have an effect of nutrition-related diseases. How gut bacteria changing (or not changing) during the day affect other microbiome-associated diseases such as Crohn’s disease or intestinal cancer may be subject to further scientific examination.